CORDIS call2024

HORIZON-HLTH-2024-IND-06

HORIZON-HLTH-2024-IND-06

Programme
HORIZON
Funded projects (dataset)
2
EU contribution (sum)
€9,654,134
Portal deadline

Leading topic in historical projects: HORIZON-HLTH-2024-IND-06-08

Start here

Suggested partners for this call

Who coordinated consortia under this call, plus a complementary slice (topic leaders, research partners, or frequent non-coordinators). For industry lists, CSV export, and consortium size — open Proposal partner finder.

Top coordinators

Organisations that coordinated the most funded projects under this call.

Organisations strong on this topic

Broader signal: frequent participants across funded projects tagged with the same topic codes as this call (not limited to coordinators).

Frequent collaborators

Pairs that often appear together in the same funded project under this call.

Proposal partner finder

One page with suggested coordinators, strong and industry partners, topic leaders, typical consortium size, similar projects — plus CSV or print / PDF export for your shortlist.

Typical consortium pattern

Derived from historical funded projects linked to this CORDIS call in Grantibase.

Avg. orgs / project
16
Median orgs / project
16
Min / max orgs
1418

Country presence

Participant rows (an org can appear in multiple countries if data varies).

  • France9
  • Germany3
  • Croatia3
  • Finland3
  • Spain2
  • Austria2
  • Ireland1
  • Portugal1
  • Norway1
  • Netherlands1
  • Belgium1
  • Greece1
  • Switzerland1
  • Slovakia1
  • Hungary1
  • United Kingdom1

Organization types

  • research_institute10 orgs · 10 rows
  • sme7 orgs · 7 rows
  • university6 orgs · 6 rows
  • other5 orgs · 5 rows
  • company4 orgs · 4 rows

Topics in funded projects

Related funded projects

Largest EU contributions in this call — useful to see who already won funding on similar lines.

Open full project list in advanced search

ProjectEU contribution
EU4MEDTECH

European Framework for Advanced Medical Technology Evaluation and Follow-up

€7,676,744
NAMWISE

NAMS WITHIN INTEGRATED SAFETY & EFFICACY EVALUATION OF CHEMICALS AND PHARMACEUTICALS

€1,977,390